Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

AMTG-DA1

  Cat. No.:  DC76424  
Chemical Structure
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
AMTG-DA1 is a Gastrin-releasing peptide receptor (GRPR) ligand. AMTG-DA1 can be used in the study of cancer.
Cas No.:
Chemical Name: AMTG-DA1
SMILES: O=C(N[C@H](C(O)=O)CCCCNC(CCCC1=CC=C(I)C=C1)=O)CCC(N2CCN(CC(O)=O)CCN(C(C(O)=O)CCC(NC(CC3)CCN3CC(N[C@@H](C(N[C@H](C(N[C@](C)(C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H]([C@H](CC(N[C@@H](CC(C)C)C(N)=O)=O)O)CC(C)C)=O)CC4=CNC=N4)=O)=O)C(C)C)=O)C)=O)CC5=CNC6=C5C=CC
Formula: C101H149In22O25
M.Wt: 2198.30
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
Cat. No. Product name Field of application
DC49271 BIM-26226 BIM-26226, gastrin-releasing peptide, is a potent and selective antagonist of bombesin receptor. BIM-26226 inhibits BN- or GRP-stimulated amylase release with IC50s in the nanomolar range. BIM-26226 can be used for the research of cancer.
DC76425 PD 165929 PD 165929 is a high affinity and competitive non-peptide neuromedin-B (NMB) receptor selective antagonist (Ki: 6.3 nM; IC50: 150 nM for rat NMB receptor).
DC76424 AMTG-DA1 AMTG-DA1 is a Gastrin-releasing peptide receptor (GRPR) ligand. AMTG-DA1 can be used in the study of cancer.
DC73384 DSO-5a DSO-5a (Dimethyl shikonin oxime 5a) is a potent, selective agonist pf bombesin receptor subtype-3 (BB3, BRS-3) with pEC50 of 8.4 (IP-1 accumulation in hBB3-H1299 cells).
X